Emerging Biological Therapies in Severe Eosinophilic Asthma.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 153, doi. 10.1007/s41030-016-0019-x
- By:
- Publication type:
- Article
Works matching IS 23641746 AND DT 2016 AND VI 2 AND IP 2
Results: 6
1
2
NIOX VERO: Individualized Asthma Management in Clinical Practice.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 171, doi. 10.1007/s41030-016-0018-y
- By:
- Publication type:
- Article
3
Economic Evaluation of Fluticasone Propionate/Formoterol (Flutiform) vs. Fluticasone/Salmeterol and Budesonide/Formoterol in Spain.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 199, doi. 10.1007/s41030-016-0021-3
- By:
- Publication type:
- Article
4
When Every Second Counts: Novel Device to Shorten Chest Tube Insertion Time in a Pre-hospital Setting.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 215, doi. 10.1007/s41030-016-0020-4
- By:
- Publication type:
- Article
5
Feasibility Study of Interactive Game Technologies to Improve Experience with Inhaler Spacer Devices in Young Children.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 189, doi. 10.1007/s41030-016-0023-1
- By:
- Publication type:
- Article
6
Severe Asthma: Challenges and Precision Approaches to Therapy.
- Published in:
- Pulmonary Therapy, 2016, v. 2, n. 2, p. 139, doi. 10.1007/s41030-016-0022-2
- By:
- Publication type:
- Article